Performance of Risk Scores in Predicting Right Ventricular Failure After LVAD Implantation

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Continuous-flow left ventricular assist devices (CF-LVADs) are vital for advanced heart failure.
• Right ventricular failure (RVF) complicates up to 40% of CF-LVAD cases, increasing morbidity and mortality.
• Accurate prediction of RVF is essential for improved patient outcomes.

Purpose of the Study:

• To evaluate and compare the predictive performance of established risk scores for RVF post-CF-LVAD implantation.
• To identify the most accurate existing score for predicting RVF in CF-LVAD recipients.

Main Methods:

• Retrospective study of 205 CF-LVAD recipients from March 2009 to May 2024.
• Comparison of RVF risk scores: Michigan, Penn/Fitzpatrick, EUROMACS, and CRITT using ROC analysis.
• Internal validation and derivation of Youden-optimized cutoffs for sensitivity and specificity.

Main Results:

• 39.5% of patients developed post-LVAD RVF.
• The EUROMACS score demonstrated the highest predictive value (C-statistic 0.670), followed by CRITT (0.653).
• Discrimination of existing RVF scores was modest, indicating a need for refinement.

Conclusions:

• The EUROMACS score performed best among evaluated risk scores for predicting RVF post-CF-LVAD.
• Existing models show modest predictive ability, highlighting the need for enhanced models using contemporary data.
• Rigorous external validation is recommended for refined RVF prediction tools.